Los Angeles Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.48M | Sell |
35,358
-169,782
| -83% | -$31.3M | 0.03% | 299 |
|
|
2025
Q4 | $30.7M | Buy |
205,140
+13,776
| +7% | +$2.25M | 0.1% | 140 |
|
|
2025
Q3 | $26.8M | Buy |
191,364
+147,006
| +331% | +$19.9M | 0.09% | 162 |
|
|
2025
Q2 | $5.57M | Buy |
44,358
+1,048
| +2% | +$131K | 0.02% | 297 |
|
|
2025
Q1 | $5.93M | Buy |
+43,310
| New | +$6.19M | 0.03% | 262 |
|
|
2024
Q4 | – | Sell |
-4,282
| Closed | -$830K | – | 1123 |
|
|
2024
Q3 | $830K | Buy |
+4,282
| New | +$896K | ﹤0.01% | 706 |
|
|
2023
Q3 | – | Sell |
-1,014
| Closed | -$289K | – | 1124 |
|
|
2023
Q2 | $289K | Sell |
1,014
-60,617
| -98% | -$18M | ﹤0.01% | 1013 |
|
|
2023
Q1 | $17.1M | Sell |
61,631
-139,445
| -69% | -$38.6M | 0.08% | 217 |
|
|
2022
Q4 | $55.7M | Buy |
201,076
+48,908
| +32% | +$13.8M | 0.27% | 92 |
|
|
2022
Q3 | $40.6M | Buy |
152,168
+111,159
| +271% | +$23.6M | 0.21% | 112 |
|
|
2022
Q2 | $8.36M | Buy |
41,009
+26,464
| +182% | +$5.41M | 0.04% | 296 |
|
|
2022
Q1 | $3.06M | Buy |
14,545
+9,490
| +188% | +$2.06M | 0.01% | 443 |
|
|
2021
Q4 | $1.21M | Buy |
5,055
+2,782
| +122% | +$715K | ﹤0.01% | 656 |
|
|
2021
Q3 | $643K | Sell |
2,273
-1,820
| -44% | -$597K | ﹤0.01% | 945 |
|
|
2021
Q2 | $1.42M | Sell |
4,093
-37,107
| -90% | -$11.2M | 0.01% | 705 |
|
|
2021
Q1 | $11.5M | Sell |
41,200
-10,679
| -21% | -$2.88M | 0.05% | 285 |
|
|
2020
Q4 | $12.7M | Sell |
51,879
-195,234
| -79% | -$50.4M | 0.05% | 242 |
|
|
2020
Q3 | $70.1M | Sell |
247,113
-6,920
| -3% | -$1.93M | 0.32% | 68 |
|
|
2020
Q2 | $68M | Buy |
254,033
+17,166
| +7% | +$5.16M | 0.33% | 75 |
|
|
2020
Q1 | $74.9M | Sell |
236,867
-163,714
| -41% | -$49.7M | 0.47% | 54 |
|
|
2019
Q4 | $119M | Buy |
400,581
+292,927
| +272% | +$81.3M | 0.59% | 33 |
|
|
2019
Q3 | $25.1M | Buy |
107,654
+13,831
| +15% | +$3.22M | 0.14% | 158 |
|
|
2019
Q2 | $21.9M | Buy |
93,823
+22,505
| +32% | +$5.2M | 0.12% | 195 |
|
|
2019
Q1 | $16.9M | Buy |
71,318
+19,834
| +39% | +$6.25M | 0.09% | 226 |
|
|
2018
Q4 | $15.5M | Buy |
51,484
+61
| +0.1% | +$19.5K | 0.1% | 214 |
|
|
2018
Q3 | $18.2M | Sell |
51,423
-131,733
| -72% | -$45.4M | 0.1% | 232 |
|
|
2018
Q2 | $53.2M | Sell |
183,156
-114,664
| -39% | -$32.2M | 0.29% | 71 |
|
|
2018
Q1 | $81.5M | Buy |
297,820
+37,730
| +15% | +$11.7M | 0.46% | 42 |
|
|
2017
Q4 | $82.9M | Buy |
260,090
+104,237
| +67% | +$33.4M | 0.45% | 45 |
|
|
2017
Q3 | $48.8M | Buy |
155,853
+13,422
| +9% | +$3.97M | 0.28% | 93 |
|
|
2017
Q2 | $38.6M | Sell |
142,431
-145,274
| -50% | -$38.4M | 0.24% | 106 |
|
|
2017
Q1 | $78.7M | Buy |
287,705
+265,851
| +1,216% | +$75.2M | 0.57% | 32 |
|
|
2016
Q4 | $6.2M | Buy |
21,854
+9,859
| +82% | +$2.92M | 0.05% | 367 |
|
|
2016
Q3 | $3.75M | Buy |
11,995
+5,450
| +83% | +$1.61M | 0.03% | 465 |
|
|
2016
Q2 | $1.58M | Buy |
6,545
+2,636
| +67% | +$695K | 0.01% | 586 |
|
|
2016
Q1 | $1.02M | Buy |
3,909
+338
| +9% | +$89.3K | 0.01% | 619 |
|
|
2015
Q4 | $1.09M | Buy |
3,571
+10
| +0.3% | +$2.87K | 0.01% | 652 |
|
|
2015
Q3 | $1.04M | Sell |
3,561
-89,466
| -96% | -$29.5M | 0.01% | 692 |
|
|
2015
Q2 | $37.6M | Sell |
93,027
-45,881
| -33% | -$18.4M | 0.35% | 82 |
|
|
2015
Q1 | $58.7M | Sell |
138,908
-15,801
| -10% | -$6.23M | 0.54% | 37 |
|
|
2014
Q4 | $52.5M | Buy |
154,709
+87,540
| +130% | +$28.3M | 0.48% | 50 |
|
|
2014
Q3 | $22.2M | Sell |
67,169
-11,021
| -14% | -$3.63M | 0.27% | 106 |
|
|
2014
Q2 | $24.7M | Sell |
78,190
-65,475
| -46% | -$19.7M | 0.24% | 126 |
|
|
2014
Q1 | $43.9M | Buy |
143,665
+119,754
| +501% | +$38M | 0.48% | 52 |
|
|
2013
Q4 | $6.68M | Sell |
23,911
-19,253
| -45% | -$4.98M | 0.07% | 289 |
|
|
2013
Q3 | $10.4M | Buy |
43,164
+16,737
| +63% | +$3.75M | 0.13% | 220 |
|
|
2013
Q2 | $5.69M | Buy |
+26,427
| New | +$5.65M | 0.08% | 271 |
|
Other funds holding BIIB
VCM
VPM
Los Angeles Capital Management's BIIB Position: Q1 2026 in Review
Los Angeles Capital Management reduced its Biogen (BIIB) stake by 83% in Q1 2026, selling an estimated $31.3M and leaving 35,358 shares worth $6.48M. The position accounts for 0.03% of the portfolio, ranked #299.
Los Angeles Capital Management first reported a position in BIIB in Q2 2013 and has held it in 47 quarters since. The position peaked at $119M in Q4 2019. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Los Angeles Capital Management held 35,358 shares of Biogen worth $6.48M as of Q1 2026.
- Los Angeles Capital Management sold 169,782 Biogen shares in Q1 2026, an estimated $31.3M.
- Biogen made up 0.03% of Los Angeles Capital Management's portfolio in Q1 2026, its #299 holding.
- Los Angeles Capital Management first reported a position in Biogen in Q2 2013 and has held it in 47 quarters since.
- Los Angeles Capital Management's Biogen position peaked at $119M in Q4 2019.
- 1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.